Skip Navigation


European Heart Journal Advance Access originally published online on October 4, 2005
European Heart Journal 2005 26(24):2673-2680; doi:10.1093/eurheartj/ehi556
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/24/2673    most recent
ehi556v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hartz, I.
Right arrow Articles by Eggen, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hartz, I.
Right arrow Articles by Eggen, A. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001

Ingeborg Hartz1,*, Inger Njølstad2 and Anne Elise Eggen1

1Department of Pharmacy, University of Tromsø, N-9037 Tromsø, Norway
2Department of Community Medicine, University of Tromsø, N-9037 Tromsø, Norway

Received 14 April 2005; revised 5 September 2005; accepted 8 September 2005; online publish-ahead-of-print 4 October 2005.

* Corresponding author. Tel: +47 977 03853; fax: +47 77 64 66 47. E-mail address: ingeborg{at}farmasi.uit.no

See page 2605 for the editorial comment on this article (doi:10.1093/eurheartj/ehi596)

Aims To study the implications of European guidelines on the use of antihypertensives and/or lipid-lowering drugs (LLDs) for primary prevention in a Norwegian population.

Methods and results The Tromsø study is a population-based study in the municipality Tromsø, Norway (from 1974 to till now). This analysis includes 45–79-year-old participants in 2001 (n=6362, attendance rate 86%). From the age of 60 years in men and 70 years in women, almost all participants were defined as high-risk individuals according to the European guidelines, with established cardiovascular disease, diabetes, or a 10-year risk score of ≥5%. In the primary prevention subgroup of the 45–64-year-olds, recommended antihypertensive and/or LLD use would be higher in men only, 42% compared with 12% on current medication. Among the 65–79-year-olds, >90% would be eligible for antihypertensives and/or LLDs in both sexes when compared with current treatment rates of <30%. In total, 40% of all participants aged 45–79 would be candidates for primary prevention, compared with 15% on current medication.

Conclusion The implementation of the European guidelines could imply a doubling of the numbers of Norwegian adults on cardiovascular medication for primary prevention. Contributors to the increase would be more frequent drug use in men and elderly people, particularly for LLD use.

Key Words: Cardiovascular disease • Guidelines • Primary prevention • Lipid-lowering drugs • Antihypertensives • Risk assessment


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Who wants to be normal?
Staffan Lindeberg
EHJ 2005 26: 2605-2606. [Extract] [Full Text]  



This article has been cited by other articles:


Home page
 Arch Intern MedHome page
S. Hallan, B. Astor, S. Romundstad, K. Aasarod, K. Kvenild, and J. Coresh
Association of Kidney Function and Albuminuria With Cardiovascular Mortality in Older vs Younger Individuals: The HUNT II Study
Arch Intern Med, December 10, 2007; 167(22): 2490 - 2496.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
S. Lindeberg
Who wants to be normal?
Eur. Heart J., December 2, 2005; 26(24): 2605 - 2606.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.